8.89
Enanta Pharmaceuticals Inc Azioni (ENTA) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2025-03-31 | 2024-12-31 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
11.99%
14.93
|
16.96 | 17.97 | 17.05 | 18.00 |
|
2.59%
39.45
|
40.50 | 42.16 | 49.82 | 52.89 |
Benefits Costs and Expenses |
1.99%
38.88
|
39.66 | 41.02 | 48.57 | 52.03 |
Costs And Expenses |
2.59%
39.45
|
40.50 | 42.16 | 49.82 | 52.89 |
Depreciation and Amortization |
35.32%
1.203
|
0.889 | 0.594 | 0.621 | 0.642 |
Operating Income/Loss |
4.18%
-24.53
|
-23.54 | -24.18 | -32.77 | -34.89 |
Nonoperating Income/Loss |
30.94%
0.578
|
0.837 | 1.132 | 1.246 | 0.857 |
Income/Loss From Continuing Operations Before Tax |
5.47%
-23.95
|
-22.71 | -23.05 | -31.52 | -34.03 |
Income Tax Expense/Benefit |
213.70%
-1.305
|
-0.416 | -0.395 | -0.363 | -0.622 |
Income/Loss From Continuing Operations After Tax |
1.59%
-22.64
|
-22.29 | -22.66 | -31.16 | -33.41 |
|
1.59%
-22.64
|
-22.29 | -22.66 | -31.16 | -33.41 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.55%
21.36
|
21.24 | 21.18 | 21.17 | 21.09 |
Diluted Average Shares |
0.55%
21.36
|
21.24 | 21.18 | 21.17 | 21.09 |
Basic Earnings Per Share |
0.95%
-1.06
|
-1.05 | -1.07 | -1.47 | -1.58 |
Diluted Earnings Per Share |
0.95%
-1.06
|
-1.05 | -1.07 | -1.47 | -1.58 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):